🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Codi #cefalea a urgències. Iniciativa de la unitat de cefalea del servei de neurologia per millora l'assistència a urgències de persones amb mal de cap. Alicia Alpuente Patricia Pozo-Rosich Edoardo Caronna Marta Torres-Ferrús Vall d'Hebron Neurociències Vall d'Hebron

Benvinguda a la nova Coordinadora i Secretaria del Grup de Cefalees de la SCatalanaNeurologia ! Gran equip Marta i Laura! Molts èxits! Marta Torres-Ferrús

Ha sido un placer compartir estos días de formación en #cefalea con otros jóvenes neurólogos. Felicidades a las organizadoras Alba López-Bravo y Sonia Quintas por el éxito de esta Reunión Junior #GECSEN!

Glad to present this recent multicenter study from 18 #headache units in Spain showing effectiveness and safety of #antiCGRP MAbs in #migraine patients > 65 years old👵🏻 Find further info on this thread:🧵 📑➡️ doi.org/10.1186/s10194… Neurologia Bellvitge Hospital Universitari Bellvitge | HUB European Headache Federation

🗣️Punt i final de l'acte "Controvèrsies en #Neurologia" del Vall d'Hebron Cemcat Vall d'Hebron Institut de Recerca 💙Gràcies als professionals que han contribuït amb coneixement i experiència i ens ha permès avançar posicions en el camp de la Neurologia #neurocienciesVH

Is there any soluble biomarker for primary headache? Patricia Pozo-Rosich Vall d'Hebron #IHC2023 #Headache #IHC2023

Our paper: “Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks” has been awarded the Cephalalgia Award Lecture at #IHC2023. We are very proud and grateful! Patricia Pozo-Rosich Alicia Alpuente Vall d'Hebron Vall d'Hebron Institut de Recerca

Does real-world evidence have a role in headache medicine? Marta Torres-Ferrús is supporting its importance at #IHC2023 debate Vall d'Hebron Vall d'Hebron Institut de Recerca

Marta Torres-Ferrús presenta las estelares de cefalea en la #RASEN23. Enhorabuena a Laura Gómez, Alicia Alpuente y al resto del equipo su trabajo destacado #NeurocienciesVH Patricia Pozo-Rosich

Are the costs of anti-CGRP monoclonal antibodies still a reason to limit their prescription in #migraine? See the results of our cost-benefit analysis! @CarlosLazaro-Hernandez Patricia Pozo-Rosich Vall d'Hebron Vall d'Hebron Institut de Recerca Neurociències Vall d'Hebron

La #migraña es una enfermedad neurológica que afecta 3 veces más a mujeres. Interfiere en la vida personal y laboral de las que la sufren y crea inequidad de genero. Hoy el #8M seguimos trabajando para reducir la carga de la migraña y contribuir a las oportunidades igualitarias

Exciting news! Cephalalgia has launched Graphical Abstracts to make key research insights more accessible and visually engaging. Stay tuned for cutting-edge #migraine and #headache science in a brand new format! International Headache Society Faraidoon Haghdoost (Big Head Pain) Nina Riggins, MD, PhD, FAAN, FAHS, UCNS Diplomate Simona Sacco Teshamae Monteith, M.D.

The GBD2021 study reveals migraine is one of the main neurological disorders, leading in DALYs, impacting 1.16 billion. Urgent public health action is needed to raise awareness, improve treatment, and advance research. journals.sagepub.com/doi/10.1177/03… Mario Peres, MD, PhD Simona Sacco

Wondering how to assess your paper’s impact? Check out this brief video from Faraidoon Haghdoost (Big Head Pain), Cephalalgia’s Social Media Editor, for expert advice. 📊✨ International Headache Society

🏆 🏆 Cephalalgia is excited to announce the Jes Olesen Awards for the Advancement of Headache Medicine! 🏆 🏆 Submit your original research in one of two categories: Basic Science 🧬 or Clinical Science 🩺, and stand a chance to win a €10,000 prize per award. The submission

An article worth reading!

This really important paper provides compelling evidence that early treatment with anti-CGRP monoclonal antibodies enhances response in the real world for migraine prevention bit.ly/3SxC6Nl

La Unidad de Cefalea ha sido reconocida con el premio Best in Class. Un orgullo recibir este galardón, recogido por la Marta Torres-Ferrús , que refleja el esfuerzo y dedicación de todo el equipo. ¡Gracias a todos por vuestro apoyo! #BIC2024 Neurociències Vall d'Hebron Patricia Pozo-Rosich Vall d'Hebron

A reflection on Headache research in 2024 May 2025 bring us energy to work on our #brain health, better treatment access policies and new #migraine disease-driven targets The Lancet The Lancet Neurology Vall d'Hebron Migraine Adaptive Brain Lab (MABLab) thelancet.com/journals/laneu…

Preventive treatment with anti-CGRP mAbs and BTX-A effectively reduces non-perimenstrual headache and non-perimenstrual migraine days but appears to have limited efficacy in perimenstrual headache and migraine days. journals.sagepub.com/doi/10.1177/03… #migraine #headache #brain #pain